← back to search

Bart Hens

KU Leuven · BE
Area of research
Pharmaceutical Science · Gastroenterology
Research interest
Research interests include Chemistry, Pharmacology, Medicine, In vivo, Drug, and Posaconazole.
h-index
citations
1,978
works
21
NIH funding
primary concept
email

Recent publications

Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation
Molecular Pharmaceutics 2024cited by 3position: middledoi
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
Proceedings of the National Academy of Sciences 2020cited by 284position: middledoi
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
Pharmaceutics 2020cited by 71position: middledoi
Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications
European Journal of Pharmaceutical Sciences 2020cited by 30position: lastdoi
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
European Journal of Pharmaceutical Sciences 2019cited by 363position: middledoi
Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses
Pharmaceutics 2019cited by 21position: middledoi
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration
European Journal of Pharmaceutics and Biopharmaceutics 2018cited by 118position: middledoi
Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach
European Journal of Pharmaceutical Sciences 2018cited by 53position: firstdoi
Application of a Dynamic Fluid and pH Model to Simulate Intraluminal and Systemic Concentrations of a Weak Base in GastroPlus™
Journal of Pharmaceutical Sciences 2018cited by 47position: firstdoi
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded ‘21st Century BA/BE’ project
International Journal of Pharmaceutics 2018cited by 46position: firstdoi
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate–CO<sub>2</sub> Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance
Molecular Pharmaceutics 2018cited by 36position: middledoi
Persistent Threats by Persistent Pollutants: Chemical Nature, Concerns and Future Policy Regarding PCBs—What Are We Heading For?
Toxics 2017cited by 95position: firstdoi
<i>In Silico</i> Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole
Molecular Pharmaceutics 2017cited by 73position: firstdoi
Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities
International Journal of Pharmaceutics 2016cited by 100position: firstdoi
Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion
Journal of Pharmaceutical Sciences 2016cited by 54position: firstdoi
Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field–Flow Fractionation/Multiangle Laser Light Scattering
Journal of Pharmaceutical Sciences 2016cited by 50position: middledoi
Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans
Journal of Pharmaceutical Sciences 2015cited by 115position: firstdoi
Gastrointestinal behavior of nano- and microsized fenofibrate: In vivo evaluation in man and in vitro simulation by assessment of the permeation potential
European Journal of Pharmaceutical Sciences 2015cited by 94position: firstdoi
Gastrointestinal transfer: In vivo evaluation and implementation in in vitro and in silico predictive tools
European Journal of Pharmaceutical Sciences 2014cited by 72position: firstdoi
A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption
European Journal of Pharmaceutical Sciences 2013cited by 194position: middledoi
Supersaturation in human gastric fluids
European Journal of Pharmaceutics and Biopharmaceutics 2012cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Patrick Augustijns · KU Leuven12 papers (2012–2020)Joachim Brouwers · KU Leuven10 papers (2012–2018)Maura Corsetti · Nottingham University Hospitals NHS Trust7 papers (2014–2020)Gordon L. Amidon · University of Michigan–Ann Arbor7 papers (2016–2024)Marival Bermejo · University of Michigan–Ann Arbor6 papers (2018–2020)Gregory E. Amidon · University of Michigan5 papers (2018–2024)Yasuhiro Tsume · University of Michigan–Ann Arbor4 papers (2018–2020)Christos Reppas · National and Kapodistrian University of Athens4 papers (2014–2020)Maria Vertzoni · National and Kapodistrian University of Athens4 papers (2014–2020)Jozef Al-Gousous · Johannes Gutenberg University Mainz4 papers (2018–2024)Peter Langguth · Johannes Gutenberg University Mainz4 papers (2018–2020)Paulo Paixão · University of Michigan–Ann Arbor3 papers (2018–2020)Niloufar Salehi · University of Michigan–Ann Arbor3 papers (2018–2024)Mirko Koziolek · Monash University3 papers (2016–2019)Luca Marciani · University of Nottingham3 papers (2016–2019)Jan Tack · KU Leuven3 papers (2012–2020)Masoud Jamei · University of Manchester2 papers (2017–2018)David B. Turner · Wright-Patterson Air Force Base2 papers (2014–2017)Pieter Annaert · KU Leuven2 papers (2012–2013) · 2 papers (2013–2018)